Categories: JobsNEWSPharma Jobs

Biocon Biologics receives MHRA UK approval for Vevzuo and Evfraxy, Denosumab Biosimilars

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) granted marketing authorisations in the United Kingdom for Vevzuo and Evfraxy, biosimilars of Denosumab.

Vevzuo is authorized for the prevention of skeletal related events (pathological fracture, radiation to bone, spinal cord compression or surgery to bone) in adults with advanced malignancies involving bone. Vevzuo is also authorized for the treatment of adults and skeletally mature adolescents with giant cell tumour of bone that is unresectable or where surgical resection is likely to result in severe morbidity.

Evfraxy is authorized for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. In postmenopausal women this significantly reduces the risk of vertebral, non-vertebral, and hip fractures.

Furthermore, Evfraxy is authorized for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures. In men with prostate cancer receiving hormone ablation, this significantly reduces the risk of vertebral fractures. Evfraxy is also authorized for the treatment of bone loss associated with long-term systemic glucocorticoid therapy in adult patients at increased risk of fracture.

Clinical data showed that both Denosumab biosimilars have comparable safety and efficacy to the reference product.

In Europe, the European Commission (EC) recently granted marketing authorisation for Biocon Biologics Denosumab biosimilars, allowing their commercialization in all European Union (EU) member states and the European Economic Area (EEA).

SWARNALATHA B

Recent Posts

Saga Lifesciences Ltd Walk-in On 21st November 2026 for QA,QC,Production,packing,Warehouse,R&D,F&D,ADL,TT

You have shared two job recruitment flyers from Saga Lifesciences Limited for upcoming walk-in interviews…

1 day ago

Acme Generics Pvt Ltd Walk-in OnSaturday, November 21, 2026 for Multiple Positions

This flyer announces a walk-in recruitment drive hosted by Acme Generics Pvt Ltd (a USFDA-approved…

1 day ago

O2h Discovery Walk-in  21st November 2026, Saturday Freshers & experience

𝗪𝗮𝗹𝗸-𝗶𝗻 𝗜𝗻𝘁𝗲𝗿𝘃𝗶𝗲𝘄 – 𝗔𝗵𝗺𝗲𝗱𝗮𝗯𝗮𝗱 o2h Discovery is conducting a walk-in interview for multiple positions across…

1 day ago